Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
In the latest session, ProMIS Neurosciences Inc (NASDAQ: PMN) closed at $0.44 up 1.63% from its previous closing price of $0.43. In other words, the price has increased by $1.63 from its previous closing price. On the day, 0.92 million shares were traded. PMN stock price reached its highest trading level at $0.4439 during the session, while it also had its lowest trading level at $0.4059.
Ratios:
For a deeper understanding of ProMIS Neurosciences Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.97 and its Current Ratio is at 0.97.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Feb 10 ’25 when Cashman Neil bought 15,000 shares for $0.97 per share. The transaction valued at 14,595 led to the insider holds 16,617 shares of the business.
Shafmaster Madge K. bought 70,000 shares of PMN for $91,028 on Sep 24 ’24. The Director now owns 208,333 shares after completing the transaction at $1.30 per share. On Sep 23 ’24, another insider, Shafmaster Madge K., who serves as the Director of the company, bought 70,000 shares for $1.28 each. As a result, the insider paid 89,656 and bolstered with 138,333 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PMN now has a Market Capitalization of 22639440 and an Enterprise Value of 18096270.
Stock Price History:
The Beta on a monthly basis for PMN is -0.12, which has changed by -0.6422764 over the last 52 weeks, in comparison to a change of 0.18189907 over the same period for the S&P500. Over the past 52 weeks, PMN has reached a high of $1.59, while it has fallen to a 52-week low of $0.38. The 50-Day Moving Average of the stock is -26.19%, while the 200-Day Moving Average is calculated to be -38.29%.
Shares Statistics:
For the past three months, PMN has traded an average of 7.89M shares per day and 5723580 over the past ten days. A total of 32.69M shares are outstanding, with a floating share count of 15.64M. Insiders hold about 52.15% of the company’s shares, while institutions hold 21.86% stake in the company. Shares short for PMN as of 1755216000 were 67218 with a Short Ratio of 0.01, compared to 1752537600 on 1767412. Therefore, it implies a Short% of Shares Outstanding of 67218 and a Short% of Float of 0.13.
Earnings Estimates
The dynamic stock of ProMIS Neurosciences Inc (PMN) is currently attracting attention from 2.0 analysts actively involved in rating its market status.The consensus estimate for the next quarter is -$0.34, with high estimates of -$0.28 and low estimates of -$0.41.
Analysts are recommending an EPS of between -$1.35 and -$1.5 for the fiscal current year, implying an average EPS of -$1.43. EPS for the following year is -$0.91, with 4.0 analysts recommending between -$0.56 and -$1.2.